Pacifica goes unbeaten in the Omicron League and advances to the CIF-SS playoffs for the first time since 2021.

Nirmatrelvir-ritonavir effectively lowers hospitalization rates and long COVID symptoms in non-hospitalized, high-risk patients with mild to moderate COVID-19.

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe ...

A 14-day course of the oral anti-inflammatory drug montelukast didn't shorten symptom duration in nonhospitalized US adults with mild or moderate COVID-19, finds a randomized controlled clinical trial ...

This page requires JavaScript to be enabled to properly display data shown within components like charts, tables, etc.. Circulation of respiratory viruses is normally ...

1-lineage variants of omicron rather than the XBB.1.5 omicron variant ... did not identify a statistical signal for ...

the percentage of younger people was almost twice as high for the omicron group compared with the delta group, and that ``could have biased the conclusions to less severe outcomes caused by omicron.'' ...

Comparative analysis with other VOCs showed Omicron as a highly divergent, monophyletic group, suggesting a unique evolutionary pathway. Conclusions: This study provides a comprehensive overview of ...

However, the quick rise of this new mutation, which is a combination of two previous omicron strains, may mean the vaccines prepared to bolster people in the colder months won’t be as effective.

Bone Metabolism and Development Research Center, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang Province 317000, People’s Republic of China Department of Orthopedics, ...